Product details


OCUFEN is indicated for:
1.the inhibition of intraoperative miosis. Ocufen does not have intrinsic mydriatic properties and does not replace mydriatic agents.
2.the management of post-operative and post-laser trabeculoplasty inflammation in the anterior segment of the eye in patients in whom steroid therapy is not recommended.
With Prescription
  • Group

    Eye Care

  • Product Subgroup

    Other Eye Conditions

  • Composition

    Flurbiprofen sodium 0.03%